Simmons Cancer Institute at Southern Illinois University is a clinical research site located in Springfield, Illinois, United States 62794.
Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Simmons Cancer Institute at Southern Illinois University has participated in 4 clinical trials.
Therapeutic areas: Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Primary Myelofibrosis.
Sponsors: TetraLogic Pharmaceuticals, Celgene, CEL-SCI Corporation.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Springfield
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Simmons Cancer Institute at Southern Illinois University has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Simmons Cancer Institute at Southern Illinois University has 4 clinical trials on record. Their work covers Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Primary Myelofibrosis.
Simmons Cancer Institute at Southern Illinois University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.